Polyvascular Disease
Polyvascular Disease is organized by Paradigm Medical Communications, LLC.
Release Date: April 28, 2023
Expiration Date: April 28, 2024
Program Overview:
Polyvascular disease, defined as atherosclerosis in 2 or more vascular beds, is associated with worse outcomes compared with single-vessel disease. Therefore, heightened vigilance and adequate pharmacologic treatment are warranted. This interactive, case-based module demonstrates appropriate treatment of a real-life patient with CAD and PAD based on the latest evidence.
Learning Objectives:
Upon completion of this activity, participants should be able to:
• Outline key clinical trial data related to the use of dual pathway inhibition (DPI) in the treatment of CAD and/or PAD
• Develop CAD and/or PAD treatment plans that demonstrate appropriate use of DPI in heterogeneous patients